Skip to main content

Table. 2 Dose-volume constraints used for OARs

From: Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer

OAR Dose-volume constraint (% of total volume)
Rectum V70Gy < 15%
V60Gy < 25%
V50Gy < 50%
Bladder V70Gy < 20%
V60Gy < 30%
V50Gy < 50%
Femoral heads V50Gy < 10%